Hemodynamic correlates of proteinuria in chronic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 10, 2011, Pages 2403-2410

  Weir, Matthew R ^a   Townsend, Raymond R ^b   Fink, Jeffrey C ^a   Teal, Valerie ^b   Anderson, Cheryl ^c   Appel, Lawrence ^c   Chen, Jing ^d   He, Jiang ^d   Litbarg, Natasha ^e   Ojo, Akinlolu ^f   Rahman, Mahboob ^a   Rosen, Leigh ^g   Sozio, Stephen M ^h   Steigerwalt, Susan ^h   Strauss, Louise ^f   Joffe, Marshall M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b University of Philadelphia   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ILLINOIS   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Street Claire Specialty Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AFRICAN AMERICAN; ARTERIAL STIFFNESS; ARTICLE; BRACHIAL ARTERY; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ETHNICITY; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEART RATE; HUMAN; KIDNEY BLOOD FLOW; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PROTEINURIA; PULSE PRESSURE; PULSE WAVE; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

AGED; AORTA; BLOOD PRESSURE; BRACHIAL ARTERY; CHRONIC DISEASE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETIC NEPHROPATHIES; FEMALE; HEMODYNAMICS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTEINURIA; PULSATILE FLOW; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 80053894909     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01670211     Document Type: Article

References (41)

1. Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D'Agostino RB, Vasan RS: Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: The Framingham Heart Study. Circulation 112: 969-975, 2005
2. Bigazzi R, Bianchi S, Baldari D, Campese VM: Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 16: 1325-1333, 1998
3. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. J Am Med Assoc 286: 421-426, 2001
4. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, Appleyard M, Jensen JS: Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110: 32-35, 2004
5. Koulouris S, Lekatsas I, Karabinos I, Ioannidis G, Katostaras T, Kranidis A, Triantafillou K, Thalassinos N, Anthopoulos L: Microalbuminuria: A strong redictor of 3-year adverse prognosis in nondiabetic patients with acute myocardial infarction. Am Heart J 149: 840-845, 2005
6. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J: Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 20: 1813-1821, 2009
7. van der Velde M, Halbesma N, de Charro FT, Bakker SJ, de ZD, de Jong PE, Gansevoort RT: Screening for albuminuria identifies individuals at increased renal risk. J Am Soc Nephrol 20: 852-862, 2009
8. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent iabetes mellitus. Lancet 1: 1430-1432, 1982
9. Weir MR: Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2: 581-590, 2007
10. Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, Wareham NJ: Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol 33: 189-198, 2004
11. Pini R, Cavallini MC, Palmieri V, Marchionni N, Di BM, Devereux RB, Masotti G, Roman MJ: Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: The ICARe Dicomano Study. J Am Coll Cardiol 51: 2432-2439, 2008
12. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, Umans JG, Howard BV: Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: The Strong Heart Study. Hypertension 50: 197-203, 2007
13. Roman MJ, Devereux RB, Kizer JR, Okin PM, Lee ET, Wang W, Umans JG, Calhoun D, Howard BV: High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol 54: 1730-1734, 2009
14. Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, Brenner BM: Effects of blood pressure level on progression of diabetic nephropathy: Results from the RENAAL study. Arch Intern Med 163: 1555-1565, 2003
15. Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de ZD, Lau J, Levey AS: Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med 135: 73-87, 2001
16. Pohl MA, Blumenthal S, Cordonnier DJ, De AF, Deferrari G, Eisner G, Esmatjes E, Gilbert RE, Hunsicker LG, de Faria JB, Mangili R, Moore J Jr, Reisin E, Ritz E, Schernthaner G, Spitalewitz S, Tindall H, Rodby RA, Lewis EJ: Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: Clinical implications and limitations. J Am Soc Nephrol 16: 3027-3037, 2005
17. Weir MR: Hypertension and the kidney: Perspectives on the relationship of kidney disease and cardiovascular disease. Clin J Am Soc Nephrol 4: 2045-2050, 2009
18. Weir MR, Townsend R: Gauging adequacy of cardiovascular disease treatment: Importance of estimating glomerular filtration rate and time-varying albuminuria. J Am Soc Hypertens 3: 277-285, 2009
19. Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, Fink JC, Franklin-Becker ED, Go AS, Hamm LL, He J, Hostetter T, Hsu CY, Jamerson K, Joffe M, Kusek JW, Landis JR, Lash JP, Miller ER, Mohler ER III, Muntner P, Ojo AO, Rahman M, Townsend RR, Wright JT: The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol 14: S148-S153, 2003
20. Townsend RR, Wimmer NJ, Chirinos JA, Parsa A, Weir M, Perumal K, Lash JP, Chen J, Steigerwalt SP, Flack J, Go AS, Rafey M, Rahman M, Sheridan A, Gadegbeku CA, Robinson NA, Joffe M: Aortic PWV in chronic kidney disease: A CRIC ancillary study. Am J Hypertens 23: 282-289, 2010
21. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern BZ: Human blood pressure determination by sphygmomanometry. Circulation 88: 2460-2470, 1993
22. DeLoach SS, Townsend RR: Vascular stiffness: Its measurement and significance for epidemiologic and outcome studies. Clin J Am Soc Nephrol 3: 184-192, 2008
23. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van LF: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-254, 2006
24. Robins JM, Rotnitzky A, Zhao LP: Analysis of semiparametric regression models for repeated outcomes in the presence of missing data. J Am Stat Assoc 90: 106-121, 1995
25. Haraldsson B, Jeansson M: Glomerular filtration barrier. Curr Opin Nephrol Hypertens 18: 331-335, 2009
26. Lea J, Greene T, Hebert L, Lipkowitz M, Massry S, Middleton J, Rostand SG, Miller E, Smith W, Bakris GL: The relationship between magnitude of proteinuria reduction and risk of endstage renal disease: Results of the African American study of kidney disease and hypertension. Arch Intern Med 165: 947-953, 2005
27. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL: Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123: 754-762, 1995
28. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993-2000, 1986
29. Agarwal R, Andersen MJ: Correlates of systolic hypertension in patients with chronic kidney disease. Hypertension 46: 514-520, 2005
30. Loutzenhiser R, Griffin K, Williamson G, Bidani A: Renal autoregulation: New perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol 290: R1153-R1167, 2006
31. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99: 2434-2439, 1999
32. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103: 987-992, 2001
33. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG: Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function? Circulation 106: 2085-2090, 2002
34. Hermans MM, Henry R, Dekker JM, Kooman JP, Kostense PJ, Nijpels G, Heine RJ, Stehouwer CD: Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: The Hoorn Study. J Am Soc Nephrol 18: 1942-1952, 2007
35. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A: Aortic stiffness is an independent predictor of all-cause and ardiovascular mortality in hypertensive patients. Hypertension 37: 1236-1241, 2001
36. Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, Havlik R, Lakatta EG, Spurgeon H, Kritchevsky S, Pahor M, Bauer D, Newman A: Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 111: 3384-3390, 2005
37. Upadhyay A, Hwang SJ, Mitchell GF, Vasan RS, Vita JA, Stantchev PI, Meigs JB, Larson MG, Levy D, Benjamin EJ, Fox CS: Arterial stiffness in mild-to-moderate CKD. J Am Soc Nephrol 20: 2044-2053, 2009
38. Clausen P, Jensen JS, Jensen G, Borch-Johnsen K, Feldt-Rasmussen B: Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 103: 1869-1874, 2001
39. Kohara K, Tabara Y, Tachibana R, Nakura J, Miki T: Microalbuminuria and arterial stiffness in a general population: The Shimanami Health Promoting Program (J-SHIPP) study. Hypertens Res 27: 471-477, 2004
40. Mule G, Cottone S, Vadala A, Volpe V, Mezzatesta G, Mongiovi R, Piazza G, Nardi E, Andronico G, Cerasola G: Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients. J Intern Med 256: 22-29, 2004
41. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 375: 2073-2081, 2010